Skip to search formSkip to main contentSkip to account menu

Fentanyl Buccal Tablet

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2011
Highly Cited
2011
BACKGROUND:Current clinical guidelines have identified the need for studies comparing the effect of different short-acting or… 
Highly Cited
2009
Highly Cited
2009
This study assessed the long‐term safety and tolerability of fentanyl buccal tablet (FBT) in opioid‐tolerant patients with cancer… 
Review
2008
Review
2008
Studies of populations with chronic cancer pain have shown a high prevalence of breakthrough pain (BTP), defined as transitory… 
Highly Cited
2007
Highly Cited
2007
Fentanyl buccal tablet (FBT) is a new opioid formulation providing rapid-onset analgesia for the treatment of breakthrough pain… 
Highly Cited
2007
Highly Cited
2007
This study assessed the absolute and relative bioavailabilities and transmucosal and gastrointestinal absorbency of fentanyl… 
Highly Cited
2007
Highly Cited
2007
ABSTRACT Background: Short-acting opioids are commonly used to treat breakthrough pain (BTP) and rapid-onset formulations are… 
2007
2007
AbstractBackground and objectives: Patients with cancer, particularly those undergoing chemotherapy or radiotherapy, may develop… 
Highly Cited
2006
Highly Cited
2006
ObjectivesCancer-related breakthrough pain (BTP) is typically managed with a short-acting oral opioid, taken as needed during a… 
2006
2006
BackgroundThe fentanyl buccal tablet (FBT) is designed to enhance the rate and extent of fentanyl absorption through the buccal…